We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Safety and Survival Profile for CAR-T Therapy Trial

News   Dec 03, 2018 | Original story from The University of Texas MD Anderson Cancer Center

 
CAR-T Therapy 2-year Survival Rates for People with B-Cell Lymphoma

Histopathology of diffuse large B-cell lymphoma occurring in the tonsil.

 
 
Advertisement
 

RELATED ARTICLES

Retracing the Lineage of Cancer Cells

News

Researchers have reconstructed the lineage history of cancer cells in two individuals with a rare blood cancer by calculating when the genetic mutation that gave rise to the disease first appeared. The findings present insights that could inform new approaches for early detection, prevention, or intervention.

READ MORE

Mutant Protein Clusters Drive Cancer-Causing Aggregates

News

A mutation that replaces a single amino acid in a potent tumor-suppressing protein turns it from saint to sinister. A new study demonstrates why this alteration is more damaging than previously thought.

READ MORE

Nanoparticle-Infused Contact Lenses Correct Color Blindness

News

Dyed contact lenses currently in development for color blindness are potentially harmful and unstable. Now, researchers have infused contact lenses with gold nanoparticles to create a safer way to see colors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE